| scholarly article | Q13442814 |
| P50 | author | Renske D. Steenbergen | Q71536042 |
| Lise M A De Strooper | Q88381372 | ||
| Daniëlle A M Heideman | Q90379334 | ||
| Chris J L M Meijer | Q90379336 | ||
| Peter J F Snijders | Q90768556 | ||
| P2093 | author name string | Johannes Berkhof | |
| Birgit I Lissenberg-Witte | |||
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| Cancer diagnostic classifiers based on quantitative DNA methylation | Q27012960 | ||
| POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women | Q30917882 | ||
| HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review | Q33762996 | ||
| A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. | Q34204227 | ||
| Phases of biomarker development for early detection of cancer | Q34311577 | ||
| A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes | Q34531028 | ||
| DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women | Q35678378 | ||
| Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3. | Q36668105 | ||
| Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women | Q36852263 | ||
| Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science | Q37170521 | ||
| Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial. | Q37503427 | ||
| Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study | Q37650670 | ||
| Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer | Q38064070 | ||
| Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials | Q38160099 | ||
| Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. | Q38213987 | ||
| The Tahoe Study: bias in the interpretation of Papanicolaou test results when human papillomavirus status is known | Q38244643 | ||
| Management of high-risk HPV-positive women for detection of cervical (pre)cancer. | Q38837737 | ||
| Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis | Q39151945 | ||
| Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis. | Q39815478 | ||
| Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC. | Q39979527 | ||
| Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer. | Q40202976 | ||
| Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands | Q40554523 | ||
| FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women | Q40651861 | ||
| Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study). | Q41027688 | ||
| Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women | Q41244440 | ||
| Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions. | Q41716644 | ||
| Combined CADM1/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women. | Q42210253 | ||
| Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer | Q42245758 | ||
| Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women | Q43661461 | ||
| Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women. | Q43719974 | ||
| Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening | Q44876752 | ||
| Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study | Q46295268 | ||
| Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial. | Q51201676 | ||
| Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy. | Q51807309 | ||
| CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease. | Q51827467 | ||
| Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer. | Q54483212 | ||
| Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. | Q54770367 | ||
| Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial | Q61626075 | ||
| Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial | Q81404025 | ||
| Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study | Q82536442 | ||
| Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening | Q83603494 | ||
| Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study | Q84818275 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cervix uterine cancer | Q160105 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1541-1548 | |
| P577 | publication date | 2018-04-27 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up | |
| P478 | volume | 143 |
| Q59352587 | Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation |
| Q92126996 | Evaluation of a methylation classifier for predicting pre-cancer lesion among women with abnormal results between HPV16/18 and cytology |
| Q58564976 | Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial |
| Q89543236 | Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions |
| Q92639475 | Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis |
| Q90731036 | Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis |
| Q91752553 | Role of FAM19A4/miR124-2 methylation analysis in predicting regression or non-regression of CIN2/3 lesions: a protocol of an observational longitudinal cohort study |
| Q95856254 | Septin 9 Methylation in Nasopharyngeal Swabs: A Potential Minimally Invasive Biomarker for the Early Detection of Nasopharyngeal Carcinoma |
| Q59349705 | The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women |
| Q92445348 | The use of molecular markers for cervical screening of women living with HIV in South Africa |
| Q91811696 | The value of cytokine levels in triage and risk prediction for women with persistent high-risk human papilloma virus infection of the cervix |
Search more.